TruAlt posts 72% revenue growth in Q3

Bengaluru based green energy conglomerate TruAlt Bioenergy Ltd has reported a strong top-line performance in the third quarter of Financial Year 2025-26, with consolidated revenue rising 72% year-on-year to Rs 7.13 billion. The company held that the performance is driven by operational scaling and capacity expansion.

However, net profit of TruAlt declined 8% to Rs 691.9 million as margins came under pressure due to higher costs linked to ongoing expansion activities.

For the quarter ended December 31, 2025, EBITDA increased 6% to Rs 1.31 billion, while EBITDA margins compressed sharply to 18.44% from 29.89% in the year-ago period. Basic earnings per share stood at Rs 8.07, compared to Rs 10.65 in Q3FY25.

Following its October 2025 IPO, TruAlt has utilised Rs 519.37 million of the Rs 750 million raised, mainly towards capital expenditure and working capital. Progress was also reported on its joint venture with Sumitomo Corporation for compressed biogas plants, with construction underway at three sites, expected to be commissioned by Q2 2027.

The company noted that ethanol operations continue to follow seasonal trends, with capacity utilisation expected to normalise as additional units become fully operational.

During the quarter, TruAlt announced key strategic developments, including the appointment of Monu Kumar as Company Secretary and Compliance Officer.

The company also entered into a strategic agreement with Honeywell on January 28, 2026, to deploy Ethanol-to-Jet (ETJ) technology for a sustainable aviation fuel facility with an envisaged annual capacity of 80,000 tonnes.

TruAlt had launched its IPO in September last year. The company leadership vowed to build one of the largest SAF plants in India. Recently, TruAlt signed an MoU with the Andhra Pradesh government to set up an SAF production unit in the state with an estimated investment of Rs 2,250 crore.